Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 102.56B | 101.89B | 99.46B | 110.67B | 112.94B |
Gross Profit | 25.38B | 28.14B | 27.61B | 31.68B | 32.48B |
EBITDA | 1.73B | 3.62B | 3.57B | 3.95B | 5.00B |
Net Income | -2.62B | 451.00M | 205.00M | 368.00M | 878.00M |
Balance Sheet | |||||
Total Assets | 55.58B | 58.19B | 54.26B | 49.37B | 50.90B |
Cash, Cash Equivalents and Short-Term Investments | 5.75B | 6.03B | 5.35B | 6.15B | 7.72B |
Total Debt | 15.31B | 15.58B | 10.42B | 5.29B | 5.48B |
Total Liabilities | 29.61B | 29.33B | 25.63B | 20.56B | 22.17B |
Stockholders Equity | 25.97B | 28.86B | 28.63B | 28.81B | 28.73B |
Cash Flow | |||||
Free Cash Flow | 1.71B | -2.79B | -4.37B | -887.00M | 1.27B |
Operating Cash Flow | 3.32B | 1.63B | 1.93B | 2.25B | 5.69B |
Investing Cash Flow | -2.40B | -3.54B | -7.13B | -3.11B | -3.60B |
Financing Cash Flow | -1.20B | 2.60B | 4.40B | -699.00M | -1.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥10.94B | 7.41 | 2.28% | 15.66% | 2.88% | ||
76 Outperform | ¥12.42B | 11.81 | 1.07% | 6.01% | -21.51% | ||
75 Outperform | ¥8.85B | 12.27 | 4.45% | 1.96% | 4.38% | ||
73 Outperform | ¥11.05B | 8.03 | 1.46% | 0.43% | 2.70% | ||
56 Neutral | ¥12.49B | ― | 2.34% | 1.28% | -449.59% | ||
53 Neutral | C$4.45B | 4.20 | -20.57% | 3.55% | 8.21% | 2.02% | |
41 Neutral | ¥8.06B | ― | ― | -10.64% | -13.47% |